1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow oltipraz: new trials by email Literature Review of oltipraz trials Research Report on oltipraz
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis Oltipraz, Placebos - Non-Alcoholic Fatty Liver Disease | Phase 3 | Completed | PharmaKing | 146 | 2019-11-15 | 2022-10-06 |
Non-alcoholic Fatty Liver Disease (1)
PharmaKing (1)
South Korea (1)
Byeongguk Jang, MD.PhD (1) · Byeonggwan Kim, MD.PhD (1) · Changuk Kim, MD.PhD (1) · Chun Kyun Lee, MD.PhD (1) · Daewon Jun, MD.PhD (1) · Doyeong Kim, MD.PhD (1) · Gapjin Chun, MD.PhD (1) · Huieon Kim, MD.PhD (1) · Hyeongjun Kim, MD.PhD (1) · Hyeonung Lee, MD.PhD (1) · Jaeyeong Chang, MD.PhD (1) · Jaeyeong Jung, MD.PhD (1) · Jaeyun Jung, MD.PhD (1) · Jihun Kim, MD.PhD (1) · Jinu Lee, MD.PhD (1)